India has the world's second highest coronavirus case count and appears to be on pace to overtake the United States in the next few weeks. To counter the rising number of infections, the country has scaled up testing. It hasn't been an easy process, but now 1 million samples are tested daily across more than 1,200 labs, and a newly-developed paper-based test that uses CRISPR gene-editing tools to detect the virus could become the third type of test — after PCR and antigen — to bolster the national diagnostic effort, BBC News reports.
The new test, called Feluda after a famous fictional Indian detective, employs a nasal swab and can return results in less than hour, making it faster than PCR tests. Its 96 percent sensitivity and 98 percent specificity rate means it will likely be more accurate than the rapid antigen tests. It would also reportedly be more affordable than both. In short, there's hope it could be the best of the both worlds. "The new test has the reliability of the PCR test, is quicker and can be done in smaller laboratories which don't have sophisticated machines," said Dr. Anurag Agarwal, the director of the Delhi-based CSIR-Institute of Genomics and Integrative Biology, where Feluda was developed.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Mountainhead: Jesse Armstrong's tech bro satire sparkles with 'weapons-grade zingers'The Week Recommends The Succession creator's first feature film lacks the hit TV show's 'dramatic richness' – but makes for a horribly gripping watch
-
10 great gifts to give dear old dad this Father's DayThe Week Recommends Make his day with a thoughtful present
-
Seeing Each Other: Portraits of Artists – a 'riveting' exhibitionThe Week Recommends Pallant House exhibition offers fascinating instances of painterly reciprocity
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influenceSpeed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreadsSpeed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
